Sandoz Group AG | WebDisclosure

PRESS RELEASE

published on 02/25/2026 at 07:00, 2 months ago

Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz reports strong full-year results for 2025 with net sales growth and core EBITDA margin expansion. The guidance for 2026 anticipates further growth in net sales and core EBITDA margin

Net Sales Growth Full-year Results Sandoz Financial Guidance 2026 Core EBITDA Margin Expansion
BRIEF

published on 02/23/2026 at 11:05, 2 months 2 days ago

Sandoz obtient l'approbation de l'UE pour Ranluspec, renforçant ainsi sa position sur le marché des biosimilaires.

Biosimilaires Ophtalmologie Commission Européenne Stratégie Sandoz Approbation Ranluspec
BRIEF

published on 02/23/2026 at 11:05, 2 months 2 days ago

Sandoz Gains EU Approval for Ranluspec, Enhancing Biosimilars Position

European Commission Biosimilars Ophthalmology Sandoz Strategy Ranluspec Approval
PRESS RELEASE

published on 02/23/2026 at 11:00, 2 months 2 days ago

Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology
Sandoz confirms European Commission approval for Ranluspec®, strengthening biosimilars leadership in ophthalmology. Launch planned for second half of 2026

Biosimilars Ophthalmology Sandoz European Commission Approval Ranluspec
BRIEF

published on 02/18/2026 at 07:05, 2 months 7 days ago

Sandoz étend l'indication d'Enzeevu® grâce à l'approbation de la FDA pour les affections rétiniennes

Approbation De La FDA Biosimilaires Sandoz Enzeevu Indications Rétiniennes
BRIEF

published on 02/18/2026 at 07:05, 2 months 7 days ago

Sandoz Expands Enzeevu® Label with FDA Approval for Retinal Indications

FDA Approval Biosimilars Sandoz Enzeevu Retinal Indications
PRESS RELEASE

published on 02/18/2026 at 07:00, 2 months 7 days ago

Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label to include multiple retinal indications, offering new treatment options for retinal diseases

FDA Approval Vision Care Sandoz Enzeevu Retinal Indications
BRIEF

published on 01/14/2026 at 12:05, 3 months 11 days ago

Sandoz Secures EU Approval for Ondibta® in Diabetes Treatment

European Commission Biosimilars Diabetes Treatment Ondibta® Approval Sandoz Strategy
BRIEF

published on 01/14/2026 at 12:05, 3 months 11 days ago

Sandoz obtient l'approbation de l'UE pour Ondibta® dans le traitement du diabète

Biosimilaires Traitement Du Diabète Commission Européenne Approbation Ondibta® Stratégie Sandoz
PRESS RELEASE

published on 01/14/2026 at 12:00, 3 months 11 days ago

Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes
Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes. Expected launch by early 2027

Diabetes European Commission Biosimilars Sandoz Ondibta

Published on 04/25/2026 at 03:10, 1 day 3 hours ago

BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 1 day 8 hours ago

Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:05, 1 day 8 hours ago

Critical Elements Pleure la perte de son administrateur Marc Simpson
Published on 04/24/2026 at 22:00, 1 day 8 hours ago

Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 1 day 15 hours ago

Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes

View all ACCESSWIRE

Published on 04/25/2026 at 16:25, 14 hours 32 minutes ago

Leading a New Era of Family Mobility! CHERY TIGGO V, the 3-in-1 Family Vehicle, Debuts at AutoChina2026
Published on 04/24/2026 at 22:43, 1 day 8 hours ago

EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 1 day 8 hours ago

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:30, 1 day 12 hours ago

EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 1 day 12 hours ago

EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting

View all EQS

Published on 04/25/2026 at 07:00, 23 hours 57 minutes ago

DLSI - Chiffre d'affaires 1er trimestre 2026
Published on 04/24/2026 at 18:48, 1 day 12 hours ago

Laboratoires Euromedis - Communiqué résultat 2025
Published on 04/24/2026 at 18:00, 1 day 12 hours ago

SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 1 day 13 hours ago

Share buyback for cancellation
Published on 04/24/2026 at 17:45, 1 day 13 hours ago

Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026

View all LES ECHOS COMFI WIRE

News